From IRO to IDRE to URAC IDR Designation: A Program Expansion Case Study

IHS Approach

Phase 1: Dual-Track Gap Analysis (Weeks 1–4)

IHS conducted a structured gap analysis across two parallel tracks:

• Federal IDRE certification track: Reviewed the client's existing operational infrastructure against CMS certification requirements — expertise documentation, conflict-of-interest policy structure, staffing capacity, case tracking systems, and reporting capabilities.
• URAC IDR Designation track: Reviewed the client's IRO-level policies and programs against the four URAC IDR Designation standard domains, identifying where IRO-level documentation was sufficient, where it needed expansion, and where new programs needed to be built.

The gap analysis was delivered as a prioritized remediation matrix — organized by domain, remediation complexity, and sequencing dependencies — with a realistic milestone schedule for both tracks.

Phase 2: Policy and Program Development (Weeks 5–14)

IHS developed new and revised documentation across both tracks simultaneously:

Conflict-of-Interest Governance

The client's existing IRO conflict-of-interest policy covered clinical reviewer independence but did not address the IDRE-specific requirement for organizational separation from payer and provider affiliates, arbitrator financial interest disclosures, or case reassignment protocols for disclosed conflicts. IHS drafted a comprehensive IDR-specific COI policy suite covering structural independence attestation, pre-assignment disclosure forms, recusal procedures, and documentation retention requirements.

Decision-Making Integrity Framework

IHS built an arbitration workflow manual covering the full IDRE case lifecycle: dispute intake and eligibility screening, offer solicitation and management, arbitrator assignment and independence confirmation, offer evaluation criteria documentation, written decision generation, 30-business-day timeline tracking, and party notification. The manual was written to satisfy both CMS certification expectations and URAC IDR Designation standards.

Data Security Controls

The client had existing data security infrastructure for IRO clinical review records. IHS conducted a focused assessment of whether those controls adequately addressed the financial and payment information specific to IDR disputes — including offer amounts, payment records, and party financial data — and documented a control mapping that met URAC's IDR Designation data security standard.

IDR-Specific CQI Program

The client's IRO CQI program covered clinical review quality metrics — reviewer qualifications, turnaround times, case auditing. IHS expanded the program to encompass IDRE-specific measures: case eligibility determination accuracy, 30-business-day compliance rate, conflict-of-interest disclosure completion rate, party selection frequency, and corrective action triggers. A quarterly IDR CQI report template was developed for leadership review.

Phase 3: Federal IDRE Certification Application (Weeks 10–16)

In parallel with policy development, IHS prepared the client's federal IDRE certification application through the CMS IDR portal. This included drafting the expertise narrative demonstrating qualifications across arbitration, claims administration, managed care, billing and coding, medical, and legal domains; assembling organizational documentation; and coordinating the submission. IHS's regulatory fluency in the No Surprises Act framework was particularly valuable in framing the expertise narrative to address the Departments' specific evaluation criteria.

Phase 4: URAC IDR Designation Application (Weeks 16–22)

With federal certification obtained and IDRE operations active, the client was eligible to pursue URAC IDR Designation. IHS managed the full URAC application process: document compilation and evidence mapping against each IDR Designation standard, narrative responses, and submission. IHS reviewed all materials through the lens of URAC reviewers — drawing on Thomas G. Goddard's firsthand experience as URAC's former COO and General Counsel to anticipate likely reviewer questions and structure evidence accordingly.

Phase 5: Reviewer Response (Weeks 23–26)

URAC reviewers issued a focused set of requests for additional information on two standards — one related to arbitrator conflict-of-interest documentation completeness, and one related to CQI corrective action documentation. IHS prepared targeted written responses for each, with supporting evidence, within the reviewer response window. No additional findings were issued after the response submission.